Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Syneos Health Inc 1030 Sync Street Morrisville NC 27560 USA

P: 919-876-9300 F: 919-876-9360

Description:

Syneos Health, Inc. is a key global biopharmaceutical solutions company offering a broad range of clinical and commercial facilities. The company majorly serves customers in the biopharmaceutical, biotechnology and medical device industries. Through its Contract Research Organization (CRO) and Contract Commercial Organization (CCO), it provides integrated and self-contained biopharmaceutical product development solutions varying from Early Phase (Phase I) clinical trials to complete commercialization of biopharmaceutical products.

Key Statistics

Overview:

Market Capitalization, $K 7,027,624
Enterprise Value, $K 7,030,330
Shares Outstanding, K 102,653
Annual Sales, $ 5,213 M
Annual Net Income, $ 234,830 K
Last Quarter Sales, $ 1,361 M
Last Quarter Net Income, $ 77,740 K
60-Month Beta 1.68
% of Insider Shareholders 0.34%
% of Institutional Shareholders 98.38%
Float, K 102,304
% Float 99.66%
Short Volume Ratio 0.48

Growth:

1-Year Return -20.39%
3-Year Return 34.66%
5-Year Return 22.25%
5-Year Revenue Growth 223.67%
5-Year Earnings Growth 69.66%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.25 on 08/02/22
Next Earnings Date N/A
Earnings Per Share ttm 4.50
EPS Growth vs. Prev Qtr 26.97%
EPS Growth vs. Prev Year 31.40%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SYNH Ratios

Ratio
Price/Earnings ttm 15.10
Price/Earnings forward 14.98
Price/Earnings to Growth N/A
Return-on-Equity % 14.04%
Return-on-Assets % 5.69%
Profit Margin % 4.50
Net Margin % N/A
Debt/Equity 0.89
Price/Sales 1.34
Price/Cash Flow 10.80
Price/Book 2.10
Book Value/Share 32.43
Interest Coverage 4.98
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar